Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase Ia/Ib clinical trial in patients with solid tumors. The company''s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

CRIS price history

interval date selector

agregation type selector

Date

Change

Chg%

Open

Min.

Max.

2022-09-30

1.1484

-0.0999

-8.00

1.2483

1.1484

1.2483

2022-09-30

1.2482

-0.0100

-0.79

1.2582

1.2283

1.3082

2022-09-30

1.2882

-0.0599

-4.44

1.3481

1.2383

1.3481

2022-09-30

1.2982

-0.0300

-2.26

1.3282

1.2982

1.3681

2022-09-30

1.3182

0.0200

1.54

1.2982

1.2882

1.3581

2022-09-30

1.3082

-0.0399

-2.96

1.3481

1.3082

1.3681

2022-09-30

1.3082

-0.0100

-0.76

1.3182

1.2682

1.3381

2022-09-30

1.2183

0.0100

0.83

1.2083

1.1783

1.2383

2022-09-30

1.1784

-0.1098

-8.52

1.2882

1.1584

1.2882

2022-09-30

1.2882

-0.0499

-3.73

1.3381

1.2283

1.3381

2022-09-30

1.3481

0.0899

7.15

1.2582

1.3681

2022-09-30

1.2283

0.1398

12.84

1.0885

1.2882

2022-09-30

1.1384

0.0100

0.89

1.1284

1.0984

1.1384

2022-09-30

1.1084

-0.0400

-3.48

1.1484

1.1084

1.1883

Trade Curis, Inc. - CRIS stock price

The Power Of Leverage

CRIS price history